 erythroid hypoplasia renal insufficiency long-term griseofulvin therapy patient hematuria pyuria eosinophiluria renal function severe anemia chronic therapy griseofulvin onychomycosis evidence griseofulvin isolated erythroid hypoplasia allergic interstitial nephritis first documented case entities agent report healthy patients drug periods time periodic determinations renal function hematologic status drug-induced erythroid hypoplasia long period dosing prudent certain individuals CBC bimonthly intervals initiation therapy Recommendations monitoring renal function difficult acute allergic interstitial nephritis short- long-term exposure certain drugs